GSTO1 and colorectal cancer: Another class of α-chloroacetamide compounds has been synthesized by Ramkumar and colleagues, among which C1-27 is recognized as the most potent GSTO1-1 inhibitor showing promising antitumor activity in both in vitro and in vivo models of colorectal cancer, without gross systemic toxicities [120].